Showing 7011-7020 of 7665 results for "".
Sunscreen Ratings, Long Live Skin Launches, SCALE Highlights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-sunscreen-ratings-long-live-skin-launches-scale-highlights/18471/Consumer Reports says that one-third of sunscreens tested in its latest evaluation provided less than half of the SPF protection touted on the label. For its part, the American Academy of Dermatology is reminding patients that sunscreen ingredients are safe. The Environmental Working Group continuesRank High in Google- Three Tiers to Online SEO Success for Doctors & Dentists
https://practicaldermatology.com/topics/practice-management/rank-high-in-google-three-tiers-to-online-seo-success-for-doctors-dentists/19132/Rank High in Google- Three Tiers to Online SEO Success for Doctors & Dentists. In this webinar, we discuss the three tier structure of a website and it's importance in helping your website rank high in Google search results. Having the right SEO and your three tiers structured properly, you canVirtual Events: Put Your Practice’s Best Face Forward
https://practicaldermatology.com/topics/practice-management/virtual-events-put-your-practices-best-face-forward/26548/Virtual Events: Put Your Practice’s Best Face ForwardDermWireTV: PCA to Space Station; ASDS Pandemic Data; LaRoche-Posay, GW Partnership
https://practicaldermatology.com/topics/practice-management/dermwiretv-pca-to-space-station-asds-pandemic-data-laroche-posay-gw-partnership/20059/The "Great Resignation" forcing some dermatology practices to operate with reduced staffing is just one of the lingering impacts of the COVID-19 pandemic on practices, according to results of a survey by the American Society for Dermatologic Surgery. PCA skin is sending the first-ever private sectorPain Relief for Next April 15th
https://practicaldermatology.com/topics/practice-management/pain-relief-for-next-april-15th--ivahevoh/18869/OJM Group Principal Carole Foos, CPA discusses strategies to help ease your individual and corporate tax burden for 2015 and years to come.To obtain a free copy of "Wealth Protection Planning for Dermatologists" visit the OJM Bookstore and enter the promo code DERMTUBE.Purified Botulinum Toxin Type A Complex for Bilateral Palmar Hyperhidrosis: A Case Report and Literature Review
https://practicaldermatology.com/programs/practical-dermatology/purified-botulinum-toxin-type-a-complex-for-bilateral-palmar-hyperhidrosis-a-case-report-literature-review/23984/A 40-year-old Caucasian woman presented to the clinic for persistent sweating of the bilateral hands, including the volar surface of the hand extending to the respective surfaces of the digits beginning approximately 20 years ago. Unsuccessful prior therapies include antiperspirants, the use of an iPatient-Centered Wound Healing
https://practicaldermatology.com/topics/feature/patient-centered-wound-healing/26645/Patient-Centered Wound HealingNoah Worcester 2024: Dr. Gold on Toxins
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gold-toxins/24583/Noah Worcester 2024: Dr. Gold on ToxinsScientifically Speaking: Investing in Innovation with Humberto Antunes
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-investing-in-innovation-with-humberto-antunes/20128/With decades of experience in dermatology and aesthetics, Humberto Antunes has helped to identify some key innovations in the field. Now part of Gore Range Capital, he continues to look for the next game-changer. He discusses his experience and shares insights on the specialties with host Joel L. CoDermWireTV: Clinical Support Tech Data; Dupixent, Stelara Updates; Rihanna Launches Fenty Skin
https://practicaldermatology.com/topics/psoriasis/dermwiretv-clinical-support-tech-data-dupixent-stelara-updates-rihanna-launches-fenty-skin/19835/A feasibility study in collaboration between LEO Innovation Lab, VisualDX, and the German Association of Dermatological Prevention supports technology to assist in diagnosis of skin conditions. Leo Pharma’s investigational JAK inhibitor delgocitinib cream is Fast Tracked by the FDA for the potentia